Skip to content

A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment of Panic Disorder

A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment of Panic Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04985019
Enrollment
40
Registered
2021-08-02
Start date
2018-11-14
Completion date
2021-01-04
Last updated
2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Disorder

Brief summary

The purpose of this study is to determine whether mobile-based virtual reality exposure treatement can reduce the symptoms of panic disorder and the symptoms of depression and anxiety than the waitlist group

Interventions

PROCEDUREArm I (Prepectoral)

Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.

Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.

Sponsors

Gangnam Severance Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

\- Meet Diagnostic Statistical Manual criteria for panic disorder(with or without agoraphobia) . No change in drug dosage during the study period

Exclusion criteria

\- Patients with a history of major neurological or significant medical illness, or met the diagnostic criteria of current substance misuse

Design outcomes

Primary

MeasureTime frameDescription
The Panic Disorder Severity Scale4 weeksThe Panic Disorder Severity Scale consists of 7 items, each rated on a 5-point scale that assesses panic frequency, distress during panic, panic-focused anticipatory anxiety, phobic avoidance of situations, phobic avoidance of physical sensations, impairment in work functioning, and impairment in social functioning

Secondary

MeasureTime frameDescription
The Hamilton Rating Scale for Depression4 weeksThe Hamilton Rating Scale for Depression is a depression assessment scale and contains 17 items pertaining to symptoms of depression experienced over the past week
The State and Trait Anxiety questionnaire4 weeksThe State and Trait Anxiety questionnaire is has 20 items for assessing trait anxiety and 20 for state anxiety
The Korean Inventory of Depressive Symptomatology4 weeksThe Korean Inventory of Depressive Symptomatology is a self-report questionnaire that comprises symptoms of depression including melancholic, atypical and anxious symptoms
The Perceived Stress Scale4 weeksThe Perceived Stress Scale is is a measure of the degree to which situations in one's life are appraised as stressful
The heart rate variability4 weeksThe heart rate variability is the physiological recordings of the variation in the time interval between consecutive heartbeats in milliseconds
The Hospital Anxiety and Depression Scale4 weeksThe Hospital Anxiety and Depression Scale is a 14-item scale that has anxiety and depression subscales;
The Body Sensations Questionnaire4 weeksThe Body Sensations Questionnaire is a 17-item 5-point Likert scale that evaluates how afraid and anxious a patient is when he/she feels the physical sensation of each item in an unstable state
The Anxiety Sensitivity Index4 weeksThe Anxiety Sensitivity Index is a 16-item measure tapping the fear of anxiety sensations, which is known to be a risk factor for the development of panic.
The Albany Panic and Phobia Questionnaire4 weeksThe Albany Panic and Phobia Questionnaire is a 27-item 9-point Likert scale that was designed to measure the distinct dimension of fear in various situations, and has three subscales: social phobia, agoraphobia, and interoceptive fear

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026